| 货号 |
中文名 |
英文名 |
品牌 |
规格 |
价格 |
详细 |
| A277-50 μg |
Adiponectin (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Adiponectin (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A278-50 μg |
Adiponectin (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Adiponectin (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A279-50 μg |
Akt1 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Akt1 Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A280-50 μg |
β-Amyloid Precursor Protein (AβNT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
β-Amyloid Precursor Protein (AβNT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A281-50 μg |
β-Amyloid Precursor Protein (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
β-Amyloid Precursor Protein (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A282-0.1 mg |
Anti-Anthrax Edema Factor Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Edema Factor |
Leinco |
0.1mg |
8602 |
More |
| A282-20ug |
Anti-Anthrax Edema Factor Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Edema Factor |
Leinco |
20μg |
1857 |
More |
| A283-0.1 mg |
Anti-Anthrax Lethal Factor (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Lethal Factor (CT) |
Leinco |
0.1mg |
8602 |
More |
| A283-20ug |
Anti-Anthrax Lethal Factor (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Lethal Factor (CT) |
Leinco |
20μg |
1857 |
More |
| A284-0.1 mg |
Anti-Anthrax Lethal Factor (Intermediate Domain) Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Lethal Factor (Intermediate Domain) |
Leinco |
0.1mg |
8602 |
More |
| A284-20ug |
Anti-Anthrax Lethal Factor (Intermediate Domain) Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Lethal Factor (Intermediate Domain) |
Leinco |
20μg |
1857 |
More |
| A285-0.1 mg |
Anti-Anthrax Protective Antigen (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Protective Antigen (CT) |
Leinco |
0.1mg |
8602 |
More |
| A285-20ug |
Anti-Anthrax Protective Antigen (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Protective Antigen (CT) |
Leinco |
20μg |
1857 |
More |
| A286-0.1 mg |
Anti-Anthrax Protective Antigen (Intermediate Domain) Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Protective Antigen (Intermediate Domain) |
Leinco |
0.1mg |
8602 |
More |
| A286-20ug |
Anti-Anthrax Protective Antigen (Intermediate Domain) Leinco-北京博迈斯科技发展有限公司 |
Anti-Anthrax Protective Antigen (Intermediate Domain) |
Leinco |
20μg |
1857 |
More |
| A287-0.1 mg |
Anti-Human Anthrax Toxin Receptor (CT) (ATR) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human Anthrax Toxin Receptor (CT) (ATR) |
Leinco |
0.1mg |
8602 |
More |
| A287-20ug |
Anti-Human Anthrax Toxin Receptor (CT) (ATR) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human Anthrax Toxin Receptor (CT) (ATR) |
Leinco |
20μg |
1857 |
More |
| A288-0.1 mg |
Anti-Human Anthrax Toxin Receptor (Intermediate Domain) (ATR) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human Anthrax Toxin Receptor (Intermediate Domain) (ATR) |
Leinco |
0.1mg |
8602 |
More |
| A289-0.1 mg |
Anti-Avian Influenza AFHA-1 Leinco-北京博迈斯科技发展有限公司 |
Anti-Avian Influenza AFHA-1 |
Leinco |
0.1mg |
8602 |
More |
| A289-20ug |
Anti-Avian Influenza AFHA-1 Leinco-北京博迈斯科技发展有限公司 |
Anti-Avian Influenza AFHA-1 |
Leinco |
20μg |
1857 |
More |
| A290-0.1 mg |
Anti-Avian Influenza AFHA-2 Leinco-北京博迈斯科技发展有限公司 |
Anti-Avian Influenza AFHA-2 |
Leinco |
0.1mg |
8602 |
More |
| A290-20ug |
Anti-Avian Influenza AFHA-2 Leinco-北京博迈斯科技发展有限公司 |
Anti-Avian Influenza AFHA-2 |
Leinco |
20μg |
1857 |
More |
| A291-0.1 mg |
Anti-Avian Influenza AFHA-3 Leinco-北京博迈斯科技发展有限公司 |
Anti-Avian Influenza AFHA-3 |
Leinco |
0.1mg |
8309 |
More |
| A288-20ug |
Anti-Human Anthrax Toxin Receptor (Intermediate Domain) (ATR) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human Anthrax Toxin Receptor (Intermediate Domain) (ATR) |
Leinco |
20μg |
1857 |
More |
| A291-20ug |
Anti-Avian Influenza AFHA-3 Leinco-北京博迈斯科技发展有限公司 |
Anti-Avian Influenza AFHA-3 |
Leinco |
20μg |
1857 |
More |
| A292-0.1 mg |
Anti-Avian Influenza AFHA-4 Leinco-北京博迈斯科技发展有限公司 |
Anti-Avian Influenza AFHA-4 |
Leinco |
0.1mg |
8602 |
More |
| A292-20ug |
Anti-Avian Influenza AFHA-4 Leinco-北京博迈斯科技发展有限公司 |
Anti-Avian Influenza AFHA-4 |
Leinco |
20μg |
2248 |
More |
| A293-0.1 mg |
Anti-Human APOBEC3G (NT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human APOBEC3G (NT) |
Leinco |
0.1mg |
8602 |
More |
| A293-20ug |
Anti-Human APOBEC3G (NT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human APOBEC3G (NT) |
Leinco |
20μg |
2248 |
More |
| A294-50 μg |
Angiotensin-Converting Enzyme 2 (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Angiotensin-Converting Enzyme 2 (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A295-50 μg |
Angiotensin-Converting Enzyme 2 (Intermediate Domain 1) Blocking Leinco-北京博迈斯科技发展有限公司 |
Angiotensin-Converting Enzyme 2 (Intermediate Domain 1) Blocking |
Leinco |
50μg |
2150 |
More |
| A296-50 μg |
Angiotensin-Converting Enzyme 2 (Intermediate Domain - 2) Blocki Leinco-北京博迈斯科技发展有限公司 |
Angiotensin-Converting Enzyme 2 (Intermediate Domain - 2) Blocki |
Leinco |
50μg |
2150 |
More |
| A297-50 μg |
Angiotensin-Converting Enzyme 2 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Angiotensin-Converting Enzyme 2 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A298-50 μg |
AFHA-1 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
AFHA-1 Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A299-50 μg |
AFHA-2 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
AFHA-2 Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A300-50 μg |
AFHA-3 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
AFHA-3 Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A301-50 μg |
AFHA-4 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
AFHA-4 Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A302-50 μg |
AID Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
AID Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A303-50 μg |
Anthrax EF Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Anthrax EF Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A304-50 μg |
Anthrax LF (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Anthrax LF (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A305-50 μg |
Anthrax LF (Intermediate Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Anthrax LF (Intermediate Domain) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A306-50 μg |
Anthrax PA (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Anthrax PA (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A307-50 μg |
Anthrax PA (Intermediate Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Anthrax PA (Intermediate Domain) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A308-50 μg |
APH1 (Intermediate Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
APH1 (Intermediate Domain) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A309-50 μg |
APH1 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
APH1 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A310-50 μg |
ATM Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
ATM Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A311-50 μg |
Anthrax Toxin Receptor (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Anthrax Toxin Receptor (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A339-50 μg |
Recombinant Human Angiogenin Leinco-北京博迈斯科技发展有限公司 |
Recombinant Human Angiogenin |
Leinco |
50μg |
12454 |
More |
| A312-50 μg |
Anthrax Toxin Receptor (Intermediate Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Anthrax Toxin Receptor (Intermediate Domain) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| A313-0.1 mg |
Anti-ACE2 (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-ACE2 (CT) |
Leinco |
0.1mg |
8602 |
More |
